Criminal immunity edit Constitutional

New Post Public Reply Private Reply Replies (0) Message Board
john1234
163

Criminal immunity
edit

Constitutional Provisions
edit
Article II, Section 4 provides for which crimes the President shall be removed from office by impeachment in the House and conviction in the Senate. Article I, Section 3, Clause 7 specifies that a President impeached by the House and convicted by the Senate is nevertheless “liable and subject to Indictment, Trial, Judgment and Punishment according to Law.”

Background
edit
A number of sources have repeated a claim that Ulysses S. Grant was arrested in office in 1872, and this has been cited in the context of presidential immunity.[18] While the Metropolitan Police Department of the District of Columbia has appeared to confirm this narrative,[19] there does not seem to be any contemporaneous documentation of it,[20] which has caused the Ulysses S. Grant National Historic Site to question its historicity.[21] A similar claim regarding Franklin Pierce has been dismissed as apocryphal by Pierce scholar Peter Wallner.[22]

Two vice presidents have been indicted: Aaron Burr in New York and New Jersey for killing Alexander Hamilton in a duel; and Spiro Agnew, who pleaded no contest to several offenses at the moment of his resignation. However, the same arguments have not been made for vice presidential immunity as for presidential.[18

OLC memoranda
edit
In 1973, amid the Watergate scandal, the Department of Justice's Office of Legal Counsel (OLC) issued a memorandum concluding that it is unconstitutional to prosecute a sitting president.[23] Its arguments include that the president "is the symbolic head of the Nation. To wound him by a criminal proceeding is to hamstring the operation of the whole governmental apparatus in both foreign and domestic affairs."[24] It says that the statute of limitations should not be tolled while the president is in office, but suggests that Congress could extend the statute of limitations specifically for presidents.[25] After the U.S. Supreme Court's decision in Clinton, the OLC issued a second memorandum in 2000, distinguishing civil and criminal presidential immunity and determining that it was still improper to prosecute a president due to the adverse affect it might have on his ability to govern.[26]

Neither memorandum has force of law, but both are binding within the Department of Justice. Because they were not promulgated with room for public comment, they do not qualify as administrative law either; rather, they are an internal prosecutorial policy.[27] The memoranda are not taken to bar investigating the president or even announcing a determination that the president has broken the law, as Nixon, Clinton, and Donald Trump have all been subject to criminal investigations while in office.[28]

Special counsel determinations and further debate
edit
The staff of Leon Jaworski, the special counsel investigating Watergate, wrote an internal memorandum in 1974 concluding that Jaworski could indict Nixon, then the sitting president. Jaworski later argued the same in court, but ultimately deferred to Congress's impeachment powers. Nixon later resigned facing impeachment. In 1998, a consultant for Ken Starr, who as independent counsel was investigating Clinton, wrote a memorandum discussing the topic at greater length and reaching the same conclusion. Starr drafted an indictment of Clinton but never filed it, instead reporting to Congress, which impeached and later acquitted Clinton.[29]

The question of presidential criminal immunity re-emerged during the presidency of Donald Trump and Robert Mueller's special counsel investigation. The Mueller report determined that Mueller was bound by the 1973 and 2000 OLC memoranda. Mueller found that he could investigate Trump, but concluded that, since he could not indict him and thereby give him the chance to defend himself, it would not be fair to label Trump's actions criminal.[30]

Amidst the investigation, Laurence Tribe argued in The Boston Globe and Lawfare that it is constitutional to prosecute a sitting president, citing a hypothetical example of a president who blatantly murders someone.[31] Philip Bobbitt in Lawfare respectfully disagreed with Tribe, in particular his logic that any president indicted after an impeachment will be pardoned by his successor (as with Gerald Ford and Richard Nixon).[32] Walter Dellinger argued that a sitting president cannot be put on trial but can still be indicted.[33]

Saikrishna Bangalore Prakash compares the OLC's reasoning to that of an "unabashed monarchist".[24] He observes a number of problems with presidential immunity from prosecution, including the question of tolling the statute of limitations.[25] Akhil Reed Amar and Brian C. Kalt see tolling as a potential solution to the problem.[34] Kim Wehle has criticized the OLC memoranda at length in The Atlantic and Stanford Law & Policy Review, highlighting that they have no force of law and could be overturned by the attorney general at any time.[35] Wehle goes as far as to say that, if necessary, federal courts should issue writs of mandamus forcing the Department of Justice to apply laws equally to the president, an extension of logic used by then-Judge Brett Kavanaugh in In re Aiken County (2011).[36]

Source

https://en.m.wikipedia.org/wiki/Presidential_...ted_States
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 527

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 116

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 350

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 63

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 554

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 356

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 270

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 462

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Large-Cap Stocks to Watch for Future Growth Opportunities

Updated Category News Views 409

Emerging Large-Cap Stocks: Evaluating Performance Last week proved to be a robust period for several large-cap stocks, demonstrating significant gains on the market. If you're looking to expand your portfolio with top performers, it's essential to keep an eye on these standout companies. AeroVironment's Spectacular Performance AeroVironment, Inc. (NASDAQ: AVAV) saw its...

Continue Reading
Celebrating 80 Years of Unity: Manchester Congress Reimagined

Updated Category News Views 373

Celebrating the Legacy of the Manchester Congress The Pan-African Progressive Front (PPF), working hand in hand with various organizations, has embarked on an exciting journey to commemorate the 80th anniversary of the historic Manchester Congress. This momentous event, pivotal in shaping pan-African unity and liberation movements, is set to stir conversations and inspire...

Continue Reading
Stifel Optimistic on Nurix's NX-5948 Ahead of ASH Presentation

Updated Category News Views 86

Stifel's Positive Adjustment for Nurix Therapeutics Stock Stifel, a well-known financial services firm, has shown renewed confidence in Nurix Therapeutics Inc. (NASDAQ: NRIX) by increasing its price target for the company’s shares from $30 to $34 while keeping a Buy rating. This optimistic outlook reflects anticipation surrounding Nurix's ongoing drug trials,...

Continue Reading
Josh Christie Steps Up as Chief Managing Partner at Ice Miller

Updated Category News Views 266

Josh Christie Steps Up as Chief Managing Partner at Ice Miller Ice Miller is excited to share that Joshua Christie will serve as its new Chief Managing Partner starting January 1, 2026. His election reflects the firm’s trust in his leadership capabilities and vision for the future. Based in the Indianapolis office, Christie has been an integral part of Ice Miller since...

Continue Reading
IPSEN's Latest Buy-Back Initiative: Weekly Summary Insights

Updated Category News Views 156

IPSEN's Buy-Back Program Overview IPSEN has embarked on an exciting buy-back program aimed at enhancing shareholder value by strategically purchasing its own shares. This initiative is not only an investment in its financial health but also reflects the confidence IPSEN has in its future. As of Week 33, 2025, a comprehensive overview of the transactions executed...

Continue Reading